The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
T-DM1 activity in metastatic HER2-positive breast cancers that received prior therapy with trastuzumab and pertuzumab.
 
Hannah Elizabeth Dzimitrowicz
No Relationships to Disclose
 
Michael J. Berger
No Relationships to Disclose
 
Craig Vargo
No Relationships to Disclose
 
Annette Hood
Employment - Bristol-Myers Squibb (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb (I)
 
Osama Abdelghany
No Relationships to Disclose
 
Akshara Singareeka Raghavendra
No Relationships to Disclose
 
Debu Tripathy
Consulting or Advisory Role - Merck; Nektar; Novartis; Oncoplex Diagnostics; Pfizer
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Merck; Novartis
 
Vicente Valero
No Relationships to Disclose
 
Lajos Pusztai
Honoraria - BioTheranostics; Pfizer
Consulting or Advisory Role - Celgene; Clovis Oncology
Research Funding - Foundation Medicine; Genentech; Merck
 
Rashmi Krishna Murthy
Consulting or Advisory Role - Daiichi Sankyo; Genentech
Travel, Accommodations, Expenses - Genentech